Eligible participants were randomized at a second visit (2
weeks before the TQD) into 1 of the 2 groups of the study in a
1:1 ratio using centrally generated block randomization with in
each site (blocks of 4with2 active and 2 placebo patches).Both
the investigators and the participants were blinded.